Search Results for: "chronic back pain management"

Source Citation GRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes—microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075-88. 36129997

In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin

Source Citation GRADE Study Research Group; Nathan DM, Lachin JM, Balasubramanyam A, et al. Glycemia reduction in type 2 diabetes—glycemic outcomes. N Engl J Med. 2022;387:1063-74. 36129996

Previous See more results in Annals of Internal Medicine

Clinical Information Search

Search Results for "chronic back pain management"

Displaying 801 - 800 of 1 in Online Learning Center

Displaying 801 - 800 of 365 in Policy Library

Displaying 801 - 800 of 2 in Performance Measures

Displaying 801 - 810 of 1307 in Annals of Internal Medicine

Severe Joint Involvement in VEXAS Syndrome: A Case Report

Myasthenia Gravis Associated With SARS-CoV-2 Infection

Genomic Analysis to Avoid Misdiagnosis of Adults With Bilateral Renal Cysts

Opioids and Chest Wall Rigidity During Mechanical Ventilation

Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors

Botulinum Toxin for Burning Mouth Syndrome

The Accuracy of Heart Rate Monitoring by Some Wrist-Worn Activity Trackers

Opioid Prescribing After Nonfatal Overdose and Association With Repeated Overdose

In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin

In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin

Displaying 801 - 800 of 95 in Annals of Internal Medicine: Clinical Cases

Displaying 801 - 800 of 53 in IM Matters

Displaying 801 - 800 of 94 in ACP Hospitalist

Displaying 801 - 800 of 9 in ACP Diabetes Monthly

Displaying 801 - 800 of 18 in ACP Gastroenterology Monthly